Perk Labs Inc (PERK.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2022 | 11-2021 | 11-2020 | 11-2019 | 11-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 95 | 97 | 76 | 411 | 429 |
| Accounts receivable | N/A | N/A | N/A | N/A | -66 |
| Other Working Capital | -94 | -23 | 34 | 1,654 | -2,021 |
| Other Operating Activity | -2,163 | -2,279 | -2,344 | -6,869 | -12,683 |
| Operating Cash Flow | $-2,162 | $-2,205 | $-2,234 | $-4,804 | $-14,342 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 28 | -2 | 0 | 5 | -380 |
| Sale Of Investment | 777 | 269 | 630 | 1,071 | N/A |
| Purchase Sale Intangibles | 0 | N/A | N/A | 0 | -1,434 |
| Investing Cash Flow | $804 | $267 | $630 | $1,076 | $-1,814 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -118 | -109 | -28 | N/A | N/A |
| Common Stock Issued | 522 | 2,677 | 622 | 0 | 11,052 |
| Common Stock Repurchased | N/A | N/A | N/A | 0 | -404 |
| Other Financing Activity | -19 | -126 | -124 | 0 | 840 |
| Financing Cash Flow | $385 | $2,442 | $470 | $0 | $11,489 |
| Beginning Cash Position | 1,287 | 784 | 1,919 | 5,646 | 10,294 |
| End Cash Position | 315 | 1,287 | 784 | 1,919 | 5,627 |
| Net Cash Flow | $-972 | $503 | $-1,135 | $-3,728 | $-4,667 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,162 | -2,205 | -2,234 | -4,804 | -14,342 |
| Capital Expenditure | 0 | -2 | N/A | -16 | -1,814 |
| Free Cash Flow | -2,162 | -2,207 | -2,234 | -4,820 | -16,156 |